France: Medicaments Containing Insulin Market 2024

Medicaments Containing Insulin Market Size in France

The French medicaments containing insulin market shrank slightly to $X in 2023, remaining relatively unchanged against the previous year. Overall, consumption saw a slight shrinkage. Medicaments containing insulin consumption peaked at $X in 2019; however, from 2020 to 2023, consumption stood at a somewhat lower figure.

Medicaments Containing Insulin Production in France

In value terms, medicaments containing insulin production totaled $X in 2023 estimated in export price. Over the period under review, production, however, continues to indicate a relatively flat trend pattern. The most prominent rate of growth was recorded in 2013 with an increase of X% against the previous year. As a result, production attained the peak level of $X. From 2014 to 2023, production growth remained at a lower figure.

Join Us at HANNOVER MESSE 2024

Don’t miss your chance to connect with us directly. Schedule a personal meeting to dive deeper into how solutions.
Hall 002, Stand C10. 22 - 26 April 2024 | Hannover, Germany

Book Your Meeting

Medicaments Containing Insulin Exports

Exports from France

In 2023, shipments abroad of medicaments containing insulin but not antibiotics was finally on the rise to reach X kg after two years of decline. Overall, exports showed a prominent expansion. The pace of growth appeared the most rapid in 2020 when exports increased by X% against the previous year. As a result, the exports reached the peak of X tons. From 2021 to 2023, the growth of the exports failed to regain momentum.

In value terms, medicaments containing insulin exports fell sharply to $X in 2023. In general, exports saw a temperate increase. The most prominent rate of growth was recorded in 2020 when exports increased by X% against the previous year. As a result, the exports reached the peak of $X. From 2021 to 2023, the growth of the exports remained at a somewhat lower figure.

Exports by Country

Gabon (X kg), the UK (X kg) and Cameroon (X kg) were the main destinations of medicaments containing insulin exports from France, with a combined X% share of total exports. Cote d'Ivoire, Benin, New Caledonia and French Polynesia lagged somewhat behind, together comprising a further X%.

From 2012 to 2023, the biggest increases were recorded for Benin (with a CAGR of X%), while shipments for the other leaders experienced more modest paces of growth.

In value terms, the UK ($X), Gabon ($X) and New Caledonia ($X) appeared to be the largest markets for medicaments containing insulin exported from France worldwide, together accounting for X% of total exports. Cameroon, Cote d'Ivoire, French Polynesia and Benin lagged somewhat behind, together accounting for a further X%.

Benin, with a CAGR of X%, recorded the highest growth rate of the value of exports, among the main countries of destination over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

In 2023, the average medicaments containing insulin export price amounted to $X per ton, waning by X% against the previous year. Over the period under review, the export price continues to indicate a abrupt shrinkage. The most prominent rate of growth was recorded in 2021 an increase of X%. The export price peaked at $X per ton in 2012; however, from 2013 to 2023, the export prices remained at a lower figure.

There were significant differences in the average prices for the major overseas markets. In 2023, amid the top suppliers, the country with the highest price was New Caledonia ($X per ton), while the average price for exports to Cote d'Ivoire ($X per ton) was amongst the lowest.

From 2012 to 2023, the most notable rate of growth in terms of prices was recorded for supplies to Gabon (X%), while the prices for the other major destinations experienced more modest paces of growth.

Medicaments Containing Insulin Imports

Imports into France

In 2023, supplies from abroad of medicaments containing insulin but not antibiotics increased by X% to X kg, rising for the second year in a row after two years of decline. Over the period under review, imports saw a strong increase. The most prominent rate of growth was recorded in 2018 when imports increased by X,000% against the previous year. Imports peaked at X tons in 2019; however, from 2020 to 2023, imports stood at a somewhat lower figure.

In value terms, medicaments containing insulin imports surged to $X in 2023. Overall, imports enjoyed a significant expansion. The growth pace was the most rapid in 2018 when imports increased by X,169%. Imports peaked in 2023 and are likely to continue growth in the immediate term.

Imports by Country

In 2023, the Netherlands (X kg) constituted the largest medicaments containing insulin supplier to France, accounting for a X% share of total imports. Moreover, medicaments containing insulin imports from the Netherlands exceeded the figures recorded by the second-largest supplier, Italy (X kg), fourfold.

From 2012 to 2023, the average annual rate of growth in terms of volume from the Netherlands was relatively modest.

In value terms, the Netherlands ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics to France, comprising X% of total imports. The second position in the ranking was taken by Italy ($X), with less than X% share of total imports.

From 2012 to 2023, the average annual growth rate of value from the Netherlands was relatively modest.

Import Prices by Country

The average medicaments containing insulin import price stood at $X per kg in 2023, growing by X% against the previous year. In general, the import price posted a significant expansion. As a result, import price reached the peak level and is likely to continue growth in the immediate term.

There were significant differences in the average prices amongst the major supplying countries. In 2023, amid the top importers, the country with the highest price was the Netherlands ($X per kg), while the price for Italy amounted to $X per kg.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Denmark (X%).

Source: IndexBox Platform